A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Study to Investigate DRP-104 in Adults With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease
- Status
- COMPLETED
- Phase
- PHASE2
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
- Status
- TERMINATED
- Phase
- PHASE1
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
- Status
- COMPLETED
- Phase
- PHASE2
Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1